Agilent Technologies Inc[2]
NEW YORK STOCK EXCHANGE, INC. · Life Sciences Tools & Services · mkt cap $39.23B
Aug 26, 2026 · Time TBD[1]
$138.57[5]
-0.9%
Agilent Technologies Inc has an upcoming earnings event; the setup should be read against consensus estimates and recent context.
| Metric | Actual | Estimate | Surprise | Verdict |
|---|---|---|---|---|
| Revenue | unavailable | unavailable | unavailable | |
| EPS | unavailable | $1.48[1] | unavailable | |
| Guidance | unavailable | |||
Event-window market reaction unavailable.
No evidence-backed AI interpretation is available for this report.
The AI service is temporarily unavailable.
| Quarter | Reported | Revenue | EPS | Gross margin | Op. margin | Net income |
|---|---|---|---|---|---|---|
| - | Aug 26, 2026 | actual: unavailableest.: unavailablesurp.: unavailable | actual: unavailableest.: $1.48[1]surp.: unavailable | unavailable | unavailable | unavailable |
| Q2 | May 27, 2026 | actual: $1.84B[6]est.: $1.8B[11]surp.: +2.0%[6+] | actual: $1.49 |
| 55.0%[6] |
| 21.7%[6] |
| $339M[6] |
| Q1 | Feb 25, 2026 | actual: $1.8B[6]est.: $1.81B[11]surp.: -0.6%[6+] | actual: $1.36[4]est.: $1.37[4]surp.: -0.7%[4] | 52.6%[6] | 19.6%[6] | $305M[6] |
| Q4 | Nov 24, 2025 | actual: $1.86B[6]est.: $1.83B[11]surp.: +1.6%[6+] | actual: $1.59[4]est.: $1.58[4]surp.: +0.6%[4] | 51.8%[6] | 23.8%[6] | $434M[6] |
| Q3 | Aug 27, 2025 | actual: $1.74B[6]est.: $1.67B[11]surp.: +4.3%[6+] | actual: $1.37[4]est.: $1.37[4]surp.: 0.0%[4] | 52.6%[6] | 20.7%[6] | $336M[6] |
| Q2 | May 28, 2025 | actual: $1.67B[6]est.: $1.63B[11]surp.: +2.6%[6+] | actual: $1.31[4]est.: $1.26[4]surp.: +4.0%[4] | 51.9%[6] | 18.0%[6] | $215M[6] |
| Q1 | Feb 26, 2025 | actual: $1.68B[6]est.: $1.67B[11]surp.: +0.7%[6+] | actual: $1.31[4]est.: $1.27[4]surp.: +3.1%[4] | 53.5%[6] | 22.4%[6] | $318M[6] |
| Q4 | Nov 25, 2024 | actual: $1.7B[6]est.: $1.67B[11]surp.: +1.7%[6+] | actual: $1.46[4]est.: $1.41[4]surp.: +3.5%[4] | 53.9%[6] | 24.0%[6] | $351M[6] |
Sourced actuals only
| Field | Current | Prior quarter | Change |
|---|---|---|---|
| Revenue | unavailable | $1.84B[6+] | unavailable |
| EPS | unavailable | $1.49[4] | unavailable |
| Gross margin | unavailable | 55.0%[6+] | unavailable |
| Guidance | unavailable | — | unavailable |
| Management tone | unavailable | — | — |
| Period | Reported | Rev act / est | EPS act / est | 1d | 5d |
|---|---|---|---|---|---|
| 2026-04-30 | May 27, 2026 | unavailable / unavailable | $1.49[4] / $1.41[4] | unavailable | unavailable |
| 2026-01-31 | Feb 25, 2026 | unavailable / unavailable | $1.36[4] / $1.37[4] | unavailable | unavailable |
| 2025-10-31 | Nov 24, 2025 | unavailable / unavailable | $1.59[4] / $1.58[4] | unavailable | unavailable |
| 2025-07-31 | Aug 27, 2025 | unavailable / unavailable | $1.37[4] / $1.37[4] | unavailable | unavailable |
| 2025-04-30 | May 28, 2025 | unavailable / unavailable | $1.31[4] / $1.26[4] | unavailable | unavailable |
| 2025-01-31 | Feb 26, 2025 | unavailable / unavailable | $1.31[4] / $1.27[4] | unavailable | unavailable |
| 2024-10-31 | Nov 25, 2024 | unavailable / unavailable | $1.46[4] / $1.41[4] | unavailable | unavailable |
| 2024-07-31 | Aug 21, 2024 | unavailable / unavailable | $1.32[4] / $1.26[4] | unavailable | unavailable |
unavailable
Nothing flagged from available data.
Transcript unavailable
No earnings-call transcript for this event. Management tone, guidance language, and Q&A pressure analysis are withheld — QVeris does not infer call intelligence without the underlying transcript.
Form 4 GlobalFoundries Inc For: 24 July By Investing.com[9]
This article reports on a Form 4 filing for GlobalFoundries Inc. on July 24. It provides a brief mention of the filing and includes general market data and related news without further details on the specific Form 4 content.
Investing.com Nigeria · unavailable
Vitalist Inc Revenue Breakdown – TSXV:VITA[9]
This article provides a revenue breakdown for Vitalist Inc (TSXV:VITA), highlighting North America as the primary contributor to its revenue. Last year, North America accounted for 3.89 million CAD, an increase from 1.15 million CAD the previous year. The data is part of the company's financial overview on TradingView.
TradingView · unavailable
IMAX Maintained by B. Riley Securities -- Price Target Raised to $52[9]
B. Riley Securities has maintained a 'Buy' rating for IMAX and raised its price target from $48.00 to $52.00, indicating confidence in the company's growth potential. However, GuruFocus identifies IMAX as 61.9% overvalued, with a GF Value™ of $26.85 against its current price of $43.47, and notes insider selling activity. Despite strong profitability and growth scores, its valuation and momentum scores are low, suggesting investors should exercise caution.
GuruFocus · unavailable
WGS 10-DAY DEADLINE ALERT: GeneDx Holdings Corp. (NASDAQ:[9]
Hagens Berman Sobol Shapiro LLP has filed a securities fraud class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS), urging investors with significant losses to come forward by the August 3, 2026, lead plaintiff deadline. The lawsuit alleges GeneDx misled investors about the benefits of its Fabric Genomics acquisition, concealing integration problems that led to a substantial impairment charge and a 49.2% stock plummet after its Q1 2026 financial results revealed missed estimates and lowered guidance. The firm is investigating alleged misrepresentations concerning the Fabric Genomics integration and its promised AI-driven efficiencies.
GlobeNewswire · unavailable
BitVentures Limited (BVC) stock price, news, quote and history[9]
This page provides a comprehensive overview of BitVentures Limited (BVC) stock, including its current price, historical data, and key financial metrics. It details the company's business in developing early-stage technology businesses, offering client referral services, and providing various insurance products. The article also presents performance data compared to the S&P 500 and lists valuation measures and financial highlights.
Yahoo Finance UK · unavailable
QVeris · get_earnings_calendar · retrieved 2026-07-25 19:32 UTC
QVeris · get_company_profile · retrieved 2026-07-25 19:32 UTC
QVeris · get_revenue_segments · retrieved 2026-07-25 19:32 UTC
QVeris · get_historical_earnings · retrieved 2026-07-25 19:32 UTC
QVeris · get_stock_quote · retrieved 2026-07-25 19:32 UTC
QVeris · get_income_statement · retrieved 2026-07-25 19:32 UTC
QVeris · get_balance_sheet · retrieved 2026-07-25 19:32 UTC
QVeris · get_cash_flow · retrieved 2026-07-25 19:32 UTC
QVeris · get_financial_news · retrieved 2026-07-25 19:32 UTC
QVeris · get_sec_filings · retrieved 2026-07-25 19:32 UTC
Missing: results, transcript, revisions